Silver Book Fact

Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.

Gin T, Luu C, Guymer R. Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD. Invest Opthalmol Vis Sci. 2011; 52(12): 9267-9274. https://iovs.arvojournals.org/article.aspx?articleid=2187859

Reference

Title
Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Gin T, Luu C, Guymer R
Volume & Issue
Volume 52, Issue 12
Pages
9267-9274
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Intensive glucose control (3 or more daily insulin injections or continuous subcutaneous insulin infusion) reduced the mean risk of retinopathy by 76% in type 1 diabetes patients who had not…  
  • Mobile Exam for DR
    Use of a mobile examination for DR screening in Finland decreased visual impairment by 86% in the covered area.  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.